Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Documentation of Sample Storage Conditions – V 2.0

Posted on By

BA-BE Studies: SOP for Documentation of Sample Storage Conditions – V 2.0

Standard Operating Procedure for Documentation of Sample Storage Conditions in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/194/2025
Supersedes SOP/BA-BE/194/2022
Page No. Page 1 of 8
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for documenting and maintaining the storage conditions of biological samples such as plasma, serum, and urine during BA/BE studies to ensure sample integrity and compliance with regulatory requirements.

2. Scope

This SOP applies to all biological samples stored in freezers or refrigerators at the bioanalytical facility throughout the duration of BA/BE studies.

3. Responsibilities

  • Sample Custodian: Ensures sample storage
conditions are monitored and documented.
  • QA Personnel: Reviews storage logs and validates compliance during internal audits.
  • Lab Technicians: Monitor temperatures and notify for excursions.
  • Bioanalytical Head: Ensures SOP adherence and CAPA implementation when required.
  • 4. Accountability

    The Head of the Bioanalytical Department is accountable for maintaining compliant and auditable records of sample storage conditions for all biological samples.

    5. Procedure

    5.1 Designated Storage Areas

    1. Samples are stored in designated:
      • Deep freezers (-70°C or lower)
      • Freezers (-20°C)
      • Refrigerators (2–8°C)
    2. Each unit must have a unique identifier (e.g., FZ-001, RF-002).

    5.2 Temperature Monitoring Devices

    1. Equip each unit with a calibrated temperature data logger or digital thermometer.
    2. Devices must be:
      • Calibrated annually
      • Placed at the center or most critical zone
    3. Attach display readers outside for quick visual check.

    5.3 Documentation of Temperature

    1. Record temperatures twice daily (start and end of shift) in Annexure-1: Sample Storage Temperature Log.
    2. Entries must include:
      • Date and time
      • Storage unit ID
      • Temperature (°C)
      • Initials of personnel
    3. Print and archive logger graphs weekly in a binder specific to each unit.

    5.4 Handling Temperature Excursions

    1. If temperature is out of acceptable range:
      • Label the storage unit as “Under Observation.”
      • Move samples to backup storage.
      • Document excursion in Annexure-2: Temperature Excursion Log.
      • Inform QA immediately.
    2. Initiate CAPA as needed and document resolution.

    5.5 Backup Power and Alarm Systems

    1. Ensure:
      • Uninterrupted Power Supply (UPS) or generator support is available.
      • Freezer units are connected to temperature alarms with 24×7 alert notification.

    5.6 Sample Inventory Mapping

    1. Each freezer must maintain an updated Sample Inventory Sheet (Annexure-3).
    2. Include:
      • Study code
      • Rack and box number
      • Sample IDs and date of placement
    3. Reconcile inventory monthly with receipt logs.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • UPS: Uninterrupted Power Supply
    • CAPA: Corrective and Preventive Action
    • °C: Degrees Celsius

    7. Documents

    1. Sample Storage Temperature Log – Annexure-1
    2. Temperature Excursion Log – Annexure-2
    3. Sample Inventory Sheet – Annexure-3

    8. References

    • ICH GCP E6(R2)
    • OECD GLP Principles
    • 21 CFR Part 58 – FDA GLP Regulations

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Sample Storage Temperature Log

    Date Time Unit ID Temperature (°C) Initials
    17/04/2025 09:00 FZ-003 -22.3 AV

    Annexure-2: Temperature Excursion Log

    Date Unit ID Observed Temp (°C) Duration Corrective Action
    16/04/2025 FZ-002 -14.2 1 hour Transferred to FZ-001

    Annexure-3: Sample Inventory Sheet

    Study Code Rack No. Box No. Sample IDs Date Placed
    BE/XYZ/2025/05 Rack-2 Box-3 SUB001 to SUB010 12/04/2025

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial SOP New Procedure QA Head
    17/04/2025 2.0 Included digital logging and excursion protocol Audit Enhancement QA Head
    See also  BA-BE Studies: SOP for Trial Registration with EudraCT - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: Creams: SOP for Change Control Management in Cream Manufacturing – V 2.0
    Next Post: Sterile Injectable Manufacturing: SOP for Calibration of Temperature Control Systems in Filling Machines – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version